July 13, 2021
Bayer Yakuhin on July 12 rolled out a dry syrup version of its anticoagulant Xarelto (rivaroxaban) for pediatric use for the treatment of venous thromboembolism (VTE). The new product requires no routine coagulation monitoring as physicians will adjust dosages based...read more